Abbott’s new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the millions of people living with diabetes in the U.S. better understand how the foods they eat affect their glucose levels. 1,2 Unlike traditional food logging apps that only give feedback after a meal is logged, Libre Assist1 helps people make informed mealtime decisions before they eat. Abbott is launching the new technology during CES 2026 in Las Vegas.

For people living with diabetes, daily health decisions are constant, and food choices are among the most critical, especially for those managing their condition solely through lifestyle changes. The challenge is intensified by each person’s unique response to food, making every meal decision complex.

“The Libre Assist1 feature is a gamechanger for me,” said Shirley Bovshow, who lives with Type 2 diabetes and is one of the first to try Abbott’s new feature. “Traditional food logging apps left me guessing. With Libre Assist1 I can see how a meal might affect my glucose before I eat2—especially helpful when dining out or trying new foods. It gives me tips to reduce the glucose impact3 and my Libre 3 Plus sensor confirms the outcome afterward. The Libre app5 has become a go-to tool for me.”

Sign up for Blog Updates